期刊文献+

门诊行为干预对PCI术后STEMI病人预后的影响

INFLUENCE OF BEHAVIOR INTERVENTION IN CLINICAL SERVICE ON PROGNOSIS OF PATIENTS WITH STEMI AFTER PCI
下载PDF
导出
摘要 目的探讨门诊行为干预对经皮冠状动脉介入治疗(PCI)后急性ST段抬高型心肌梗死(STEMI)病人预后的影响。方法选择行PCI术的STEMI病人160例,随机分为实验组与对照组,各80例。两组病人住院治疗期间均给予个体化的知识教育和行为干预,在此基础上,实验组病人出院后仍进行每月1次门诊行为干预。随访24个月,比较两组病人的主要不良心脏事件发生情况。结果两组病人的全因死亡和非致死性心肌梗死发生率差异无显著意义(P>0.05)。实验组的不稳定型心绞痛和心力衰竭发生率低于对照组(χ2=4.103、4.444,P<0.05),复合心血管不良事件发生率也明显低于对照组(χ2=4.592,P<0.05)。结论实施门诊行为干预措施,帮助病人建立健康的行为方式,可降低PCI术后STEMI病人主要心血管不良事件发生率,改善临床预后。 Objective To investigate the influence of behavior intervention in clinical service on prognosis in patients with post-PCI acute STEMI. Methods A total of 160 post-PCI STEMI patients were evenly randomized to intervention group and control group. All the patients were given individualized knowledge education and behavior intervention. Those in the intervention group still received post-discharge behaviour intervention at outpatient clinic, once a month. The incidence of major adverse cardiac events (MACE) were recorded and compared between the two groups during the 24-month follow-up. Results There was no significant difference in all cause mortality and the incidence of non-fatal myocardial infarction between the two groups (P〉0.05). Both the incidence of unstable angina and heart failure were lower in the intervention group than that in the control (x^2= 4. 103, 4. 444;P〈0.05), and the combined incidence rate of MACE was lower as well (Z2 =4. 592 ,P〈0. 05). Conclusion Practice of clinical intervention can help patients create a healthy life style, reduce MACE in post PCI STEMI and improve their prognosis.
出处 《齐鲁医学杂志》 2013年第1期71-72,75,共3页 Medical Journal of Qilu
关键词 心肌梗死 血管成形术 经腔 经皮冠状动脉 干预性研究 行为疗法 myocardial infarction angioplasty, transluminal, percutaneous coronary intervention studies behavior therapy
  • 相关文献

参考文献9

  • 1DOUGLASPZ.BRAUNWAI.D心脏病学[M].陈灏珠主译.7版.北京:人民卫生出版社,2007:1648-1651.
  • 2MENEZES A R, LAVIE C J, MILANI R V, et al. Psycho logical risk factors and cardiovascular disease: is it all in your head[J]. Postgrad Med, 2011,123(5) :165-176.
  • 3美国心肺康复协会.美国心脏康复和二级预防项目指南[M].4版.王增武主译.北京:人民军医出版社,2010:6-23.
  • 4VRANCKX P, BOERSMA E, GARG S, et al. Cardiovascular risk profile of patients included in stent trials= a pooled analy sis of individual patient data from randomized clinical trials: insights from 33 prospective stent trials in Europe[J]. Eu- rolntervention, 2011,7(7) :859-871.
  • 5岳娟,汪韶洁,逄增昌,张东峰,高维国,孙月琳.青岛市35~74岁居民血脂异常患病率及相关因素分析[J].青岛大学医学院学报,2012,48(2):98-100. 被引量:22
  • 6MARTiNEZ-GONZALEZ M A, GARCiA LOPEZ M, BES RASTROLLO M, et al. Mediterranean diet and the incidence of cardiovascular disease: a Spanish cohort[J]. Nutr Metab Cardiovasc Dis, 2011,21(4) :237-244.
  • 7张雪飞,叶新钢,荣敦国,聂怀利.量化运动干预对成人肥胖指数的影响[J].青岛大学医学院学报,2010,46(6):492-494. 被引量:4
  • 8代薇,杨祖福.心肺运动试验与冠心病康复[J].中国康复理论与实践,2010,16(10):947-949. 被引量:26
  • 9JOLLY K, TAYLOR R, LIP G Y, et al. The Birmingham re-habilitation uptake maximisation study (Brum). home-based compared with hospital-based cardiac rehabilitation in a multi- ethnic population: cost-effectiveness and patient adherence[J]. Health Technology Assessment ( Winchester, England ), 2007,11(35) :1-118.

二级参考文献25

  • 1马文军,许燕君,傅传喜,陈美芬,徐浩锋,李剑森,聂少萍.广东省≥15岁居民血脂异常分布特征及影响因素[J].华南预防医学,2006,32(5):1-5. 被引量:11
  • 2张捷,胡晓舟,李振荣.急性心肌梗死后康复运动患者的心脏功能评价[J].中国实验诊断学,2006,10(11):1266-1269. 被引量:6
  • 3黄建始.什么是健康管理?[J].中国健康教育,2007,23(4):298-300. 被引量:143
  • 4WHO.Definition,diagnosis and classification of diabetes melli-tus and its complications,report of a WHO consultation.part1.Diagnosis and classification of diabetes mellitus[R].Gene-va:WHO,1999:1-20.
  • 5WANG Y R,AlEXANDER G C,MELRZER D O.Screening andtreatment of hypercholesterolemia for prevention of coronary heartdisease[J].Manage Care Interface,2006,19(1):25-29.
  • 6HAMADECH M J,DEVRIES M C,TARNOPOLSKY M A.ESRROGEN supplementation reduces whole body leucine andcarbohydrate oxidation and increases lipid oxidation in menduring endurance exercise[J].J Clin Endocrinol Metab,2005,90(6):3592-3599.
  • 7BOURGAULT C,DAVIGNON J,FODOR G,et al.Statintherapy in Canadian patients with hypercholesterolemia:theCanadian Lipid Study-Observational(CALIPSO)[J].Can JCardiol,2005,21(13):1187-1193.
  • 8ALAM S M,ALIS,KHALIL M,et al.Serum lipid profile in hy-pertensive and normotensive typeⅡdiabetes mellitus patients——acomparative study[J].Mymensingh Med J,2003,2(1):12-16.
  • 9TAN C E,ChEW L S,TAI E S,et al.Benefits of micronisedFenofibrat e in type 2diabetes mellitus subjects with good gly-cemic control[J].Atherosclerosis,2001,154:469-474.
  • 10方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3068

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部